Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Chronic-Phase

Explore clinical trials studying Leukemia, Myeloid, Chronic-Phase. Study availability and eligibility vary by location and protocol.

314 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Chronic-Phase trial results

Active, not recruiting

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

NCT04258943

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 59 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)

NCT04160546

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations
  • Institut Català D'Oncologia L'Hospitalet (ICO) L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital General Universitario Gregorio Marañón Madrid, Spain
  • Hospital Ramón y Cajal Madrid, Spain
  • Hospital Universitario y Politécnico La Fe Valencia, Spain
View all 13 locations
View Trial Details
Active, not recruiting

Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia

NCT04147533

Conditions
Bone Marrow Diseases, Chemically-Induced Disorders, Chronic Disease, +17 more
Locations
  • University Hospital Brno Brno, Czechia
  • University Hospital Hradec Kralove Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Ostrava Ostrava, Czechia
View Trial Details
Completed

Pioglityazone and Imatinib for CML Patients

NCT02888964

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • CHR Annecy Annecy, France
  • Institut Bergonié Bordeaux, France
  • CH Versailles Le Chesnay, France
  • CHU Lille Lille, France
View Trial Details
Completed

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

NCT02467270

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Indiana Blood & Marrow Transplantation Indianapolis, Indiana, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
  • Michigan Medicine Ann Arbor, Michigan, United States
View all 86 locations
View Trial Details
Completed

Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation

NCT04666259

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Arizona Oncology Associates Phoenix, Arizona, United States
  • Cancer Treatment Centers of America Phoenix, Arizona, United States
  • Pacific Shores Medical Group Long Beach, California, United States
View all 26 locations
View Trial Details
Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions